Literature DB >> 21516439

End-systolic versus end-diastolic late gadolinium enhanced imaging for the assessment of scar transmurality.

Andreas Schuster1, Amedeo Chiribiri, Masaki Ishida, Geraint Morton, Matthias Paul, Shazia Hussain, Boris Bigalke, Divaka Perera, Eike Nagel.   

Abstract

Late gadolinium enhancement (LGE) is widely used to precisely localize and determine the extent and transmurality of myocardial scarring. Performing LGE imaging at end-systole may reduce motion artefacts. It is therefore important to know whether end-systolic imaging influences infarct transmurality in patients with ischemic scar. 107 dysfunctional segments were studied in 20 consecutive patients with established coronary artery disease. Patient specific trigger delays were used to obtain end-diastolic and end-systolic LGE images (LGE(ed), LGE(es)). Wall thickness (WT(ed), WT(es)), thickness of the remaining viable rim (RIM(ed), RIM(es)) and end-diastolic scar thickness were measured manually. There was LGE in 84% of all dysfunctional segments with a mean scar of 3.4 ± 2.5 mm. Total wall thickness and the thickness of the remaining viable rim increased from diastole to systole (WT(ed) 7.8 ± 1.9 vs. WT(es) 8.4 ± 2.2; P < 0.001; RIM(ed) 4.4 ± 3.1 vs. RIM(es) 5 ± 3.4; P < 0.001). Transmurality of scar decreased from end-diastole to end-systole (LGE(ed) 46 ± 33% vs. LGE(es) 44 ± 33%; P < 0.001). This was most pronounced in a subgroup of segments (n = 15) with visual scar transmurality between 50 and 75% (LGE(ed) 75 ± 15% vs. LGE(es) 70 ± 16%; P < 0.001). The change in transmurality was inversely correlated with the change of the thickness of the remaining viable rim between diastole and systole (r = -0.7; P < 0.001). Scar transmurality was reduced by up to 12% in the individual patient. Scar transmurality changes due to thickening of the remaining viable rim. Whereas these differences might not impact on clinical decision-making in most patients, there will be an occasional misclassification if cut-off values are used (e.g. scar <50 or >50%) or if exact data is required for research studies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21516439     DOI: 10.1007/s10554-011-9877-3

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  15 in total

1.  Guidelines on myocardial revascularization.

Authors:  William Wijns; Philippe Kolh; Nicolas Danchin; Carlo Di Mario; Volkmar Falk; Thierry Folliguet; Scot Garg; Kurt Huber; Stefan James; Juhani Knuuti; Jose Lopez-Sendon; Jean Marco; Lorenzo Menicanti; Miodrag Ostojic; Massimo F Piepoli; Charles Pirlet; Jose L Pomar; Nicolaus Reifart; Flavio L Ribichini; Martin J Schalij; Paul Sergeant; Patrick W Serruys; Sigmund Silber; Miguel Sousa Uva; David Taggart
Journal:  Eur Heart J       Date:  2010-08-29       Impact factor: 29.983

2.  Shortening without contraction: new insights into hibernating myocardium.

Authors:  Eike Nagel; Andreas Schuster
Journal:  JACC Cardiovasc Imaging       Date:  2010-07

3.  Contractile reserve in segments with nontransmural infarction in chronic dysfunctional myocardium using low-dose dobutamine CMR.

Authors:  Sharon W Kirschbaum; Alexia Rossi; Ron T van Domburg; Katerina Gruszczynska; Gabriel P Krestin; Patrick W Serruys; Dirk J Duncker; Pim J de Feyter; Robert-Jan M van Geuns
Journal:  JACC Cardiovasc Imaging       Date:  2010-06

4.  Late gadolinium-enhanced cardiovascular MRI at end-systole: feasibility study.

Authors:  Hidenari Matsumoto; Tetsuya Matsuda; Kenichi Miyamoto; Toshihiko Shimada; Atsushi Hayashi; Mikiko Mikuri; Yuji Hiraoka
Journal:  AJR Am J Roentgenol       Date:  2010-11       Impact factor: 3.959

5.  Late gadolinium-enhanced magnetic resonance imaging in acute and chronic myocardial infarction. Improved prediction of regional myocardial contraction in the chronic state by measuring thickness of nonenhanced myocardium.

Authors:  Yasutaka Ichikawa; Hajime Sakuma; Naohisa Suzawa; Kakuya Kitagawa; Katsutoshi Makino; Tadanori Hirano; Kan Takeda
Journal:  J Am Coll Cardiol       Date:  2005-03-15       Impact factor: 24.094

6.  Reproducibility of chronic and acute infarct size measurement by delayed enhancement-magnetic resonance imaging.

Authors:  Holger Thiele; Mathias J E Kappl; Stefan Conradi; Josef Niebauer; Rainer Hambrecht; Gerhard Schuler
Journal:  J Am Coll Cardiol       Date:  2006-03-27       Impact factor: 24.094

7.  Cardiac magnetic resonance imaging at 3 and 15 months after application of circulating progenitor cells in recanalised chronic total occlusions.

Authors:  Holger Thiele; Andreas Schuster; Sandra Erbs; Axel Linke; Karsten Lenk; Volker Adams; Rainer Hambrecht; Gerhard Schuler
Journal:  Int J Cardiol       Date:  2008-06-26       Impact factor: 4.164

8.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

9.  Assessment of coronary artery disease using magnetic resonance coronary angiography: a national multicenter trial.

Authors:  Shingo Kato; Kakuya Kitagawa; Nanaka Ishida; Masaki Ishida; Motonori Nagata; Yasutaka Ichikawa; Kazuhiro Katahira; Yuji Matsumoto; Koji Seo; Reiji Ochiai; Yasuyuki Kobayashi; Hajime Sakuma
Journal:  J Am Coll Cardiol       Date:  2010-09-14       Impact factor: 24.094

10.  Magnetic resonance low-dose dobutamine test is superior to SCAR quantification for the prediction of functional recovery.

Authors:  Ernst Wellnhofer; Adriana Olariu; Christoph Klein; Michael Gräfe; Andreas Wahl; Eckart Fleck; Eike Nagel
Journal:  Circulation       Date:  2004-04-26       Impact factor: 29.690

View more
  4 in total

Review 1.  Cardiovascular imaging 2012 in the International Journal of Cardiovascular Imaging.

Authors:  Hiram G Bezerra; Ricardo A Costa; Johan H C Reiber; Frank J Rybicki; Paul Schoenhagen; Arthur A Stillman; Johan De Sutter; Nico R L Van de Veire; Ernst E van der Wall
Journal:  Int J Cardiovasc Imaging       Date:  2013-04       Impact factor: 2.357

2.  Functional LGE Imaging: Cardiac Phase-Resolved Assessment of Focal Fibrosis.

Authors:  Sebastian Weingartner; Omer Burak Demirel; Chetan Shenoy; Lothar R Schad; Jeanette Schulz-Menger; Mehmet Akcakaya
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2019-07

3.  Assessment of myocardial injury after reperfused infarction by T1ρ cardiovascular magnetic resonance.

Authors:  Rutger H Stoffers; Marie Madden; Mohammed Shahid; Francisco Contijoch; Joseph Solomon; James J Pilla; Joseph H Gorman; Robert C Gorman; Walter R T Witschey
Journal:  J Cardiovasc Magn Reson       Date:  2017-02-15       Impact factor: 5.364

4.  Cardiac phase-resolved late gadolinium enhancement imaging.

Authors:  Sebastian Weingärtner; Ömer B Demirel; Francisco Gama; Iain Pierce; Thomas A Treibel; Jeanette Schulz-Menger; Mehmet Akçakaya
Journal:  Front Cardiovasc Med       Date:  2022-09-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.